A national survey finds patients want personal contact after positive cancer results, with psychosocial fears outweighing cost and transportation concerns. Pharmacy-based colorectal cancer (CRC) ...

Close to 50,000 Americans will die from colorectal cancer (CRC) in 2016, making it the second-leading cause of cancer-related death in this country (behind only lung cancer).1 What makes the statistic ...

FIT outperformed cfDNA in detecting advanced precancerous colorectal lesions, showing higher sensitivity and specificity. Blood-based tests offer easier implementation and potentially higher adherence ...

Please provide your email address to receive an email when new articles are posted on . People in rural areas experience a variety of barriers to CRC screening. A mailed fecal immunochemical test ...

A simulation model has shown a hybrid colorectal cancer screening process to be clinically and cost effective, according to The Oncology Report. The method includes an annual fecal immunological test ...

Colorectal cancer incidence and mortality have increased among younger adults in recent years, with the most significant increase seen in those ages 40 to 49. Starting FIT screening early was tied to ...

Chaoyuan Kuang, MD, PhD, Co-Leader, GI Clinical and Translational Research, at Montefiore Einstein Comprehensive Cancer Center, and Othon Wiltz, MD, Colon and Rectal Surgeon, for Montefiore Einstein ...

An investigational multitarget stool DNA test for screening colorectal cancer detects significantly more cancers than the currently available fecal immunochemical test (FIT), researchers report. But ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...

Colorectal cancer was once considered primarily a disease of aging. But rates are now on the rise among younger adults. Since 2011, colon cancer rates among people younger than 50 have increased by ...